Expression of protein C (PC), protein S (PS) and thrombomodulin (TM) in human colorectal cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Thrombosis Research

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.thromres.2009.09.011PMID 19818470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of hemostatic system inhibitors in malignancy.

  2007cited by this paper
• Massive infiltration of bone marrow in colon carcinoma after treatment with activated protein C

  2007cited by this paper
• Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1.

  2007cited by this paper
• Inflammation and the activated protein C anticoagulant pathway.

  2006cited by this paper
• Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival

  2006cited by this paper
• Heterogeneous Expression of Protein C (PC), Protein S (PS) and Thrombomodulin (TM) in Human Colon Cancer Tissue.

  2006cited by this paper
• Silencing of the thrombomodulin gene in human malignant melanoma

  2005cited by this paper
• Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

  2005cited by this paper
• Contribution of the hemostatic system to angiogenesis in cancer.

  2004cited by this paper
• Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo

  2004cited by this paper
• Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3.

  2004cited by this paper
• Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

  2003cited by this paper
• Protein S Confers Neuronal Protection During Ischemic/Hypoxic Injury in Mice

  2003cited by this paper
• Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells

  2003cited by this paper
• Molecular recognition in the protein C anticoagulant pathway

  2003cited by this paper
• Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.

  2003cited by this paper
• Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.

  2003cited by this paper
• Resistance to Activated Protein C, Factor V Leiden and the Prothrombin G20210A Variant in Patients with Colorectal Cancer

  2002cited by this paper
• Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells.

  2002cited by this paper
• Aortic Thrombosis After Low Anterior Resection for Rectal Cancer

  2002cited by this paper
• Relationship of Coagulation Test Abnormalities to Tumour Burden and Postoperative DVT in Resected Colorectal Cancer

  2002cited by this paper
• Expression and Anticoagulant Function of the Endothelial Cell Protein C Receptor (EPCR) in Cancer Cell Lines

  2001cited by this paper
• Role of Coagulation Inhibitors in Inflammation

  2001cited by this paper
• Incidence of deep vein thrombosis after colorectal surgery in a Chinese population

  2001cited by this paper
• Expression of Gelatinase-A (MMP-2) in Human Colon Cancer and Normal Colon Mucosa

  2001cited by this paper
• Localization of Blood Coagulation Factors In Situ in Pancreatic Carcinoma

  2001cited by this paper
• Prognostic significance of thrombomodulin expression and vascular invasion in stage I squamous cell carcinoma of the lung.

  2001cited by this paper
• Expression of thrombomodulin in squamous cell carcinoma of the lung: its relationship to lymph node metastasis and prognosis of the patients.

  2000influential reference
• Activated Protein C Directly Activates Human Endothelial Gelatinase A*

  2000cited by this paper
• Thrombosis in cancer patients.

  2000cited by this paper
• The Endothelial Cell Protein C Receptor

  2000cited by this paper
• Synthesis and secretion of the anticoagulant protein S and coexpression of the Tyro3 receptor in human lung carcinoma cells

  1999cited by this paper
• Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.

  1998cited by this paper
• Thrombin receptor overexpression in malignant and physiological invasion processes

  1998cited by this paper
• Outcome after proctectomy for rectal cancer in Department of Veterans Affairs Hospitals: a report from the National Surgical Quality Improvement Program.

  1998cited by this paper
• Hypercoagulable State in Patients with Advanced Gastrointestinal Cancer: Evidence for an Acquired Resistance to Activated Protein C

  1997cited by this paper
• Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study.

  1997cited by this paper
• Activated-protein-C resistance in cancer patients.

  1997cited by this paper
• Anticoagulant Properties of the Vascular Endothelium

  1997cited by this paper
• Pre- and Postoperative State of Coagulation and Fibrinolysis in Plasma of Patients with Benign and Malignant Colorectal Disease - A Preliminary Study

  1996cited by this paper
• Prognostic value and clinicopathological correlation of thrombomodulin in squamous cell carcinoma of the human lung.

  1996cited by this paper
• Solid tumor cells express functional "tethered ligand" thrombin receptor.

  1995cited by this paper
• Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis.

  1995cited by this paper
• Protein S, an Antithrombotic Factor, Is Synthesized and Released by Neural Tumor Cells

  1993cited by this paper
• Pathways of Coagulation/Fibrinolysis Activation in Malignancy

  1992cited by this paper
• Prognostic significance of blood coagulation tests in carcinoma of the lung and colon

  1992cited by this paper
• Protein C activity, stage of disease, and vascular thrombosis in colon carcinoma.

  1992cited by this paper
• Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue

  1991cited by this paper
• Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung

  1990cited by this paper
• Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.

  1990cited by this paper
• Pre- and postsurgery activation of blood coagulation in gastric and large bowel cancers: diagnostic, therapeutic and prognostic hints.

  1990cited by this paper
• Indirect Activation of Blood Coagulation in Colon Cancer

  1989influential reference
• Thromboembolic problems in colorectal cancer surgery.

  1988cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper

• Quantitative proteomics analysis of papillary thyroid carcinoma reveals protein S, clusterin, and leucine-rich α-2-glycoprotein 1 as potential prognostic protein biomarkers

  2025cites this paper
• Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway

  2025cites this paper
• PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification.

  2023cites this paper
• Identi cation of Subtype-Speci c Prognostic Biomarkers in Breast Cancer

  2022cites this paper
• Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy

  2021cites this paper
• Aberrant expression of PROS1 correlates with human papillary thyroid cancer progression

  2021cites this paper
• TYRO3: A potential therapeutic target in cancer

  2019cites this paper
• Co-localization of Coagulation Factor X and its Inhibitory System, PZ/ZPI, in Human Endometrial Cancer Tissue

  2019cites this paper
• Clinical and prognostic significance of hypercoagulability in patients with metastatic colorectal cancer

  2019cites this paper
• Targeting Gas6/TAM in cancer cells and tumor microenvironment

  2018cites this paper
• Effect of Huisheng oral solution on coagulation function in perioperative period in patients with primary lung cancer.

  2017cites this paper
• Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT)

  2016cites this paper
• Venous thromboembolism in patients with cancer undertaking chemotherapy

  2015cites this paper
• IDENTIFYING MEDIATORS OF ANDROGEN-INDEPENDENT PROSTATE CANCER USING MASS SPECTROMETRY-BASED PROTEOMICS

  2014cites this paper
• Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers

  2014cites this paper
• Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer

  2013cites this paper
• Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer.

  2013cites this paper
• Proteomic Profiling of Androgen-independent Prostate Cancer Cell Lines Reveals a Role for Protein S during the Development of High Grade and Castration-resistant Prostate Cancer

  2012cites this paper
• Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.

  2012cites this paper
• The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner.

  2012cites this paper
• Regulation of thrombomodulin expression in prostate cancer cells.

  2012cites this paper
• SHP2-dependent manner induced angiogenesis events in a Mer- and - multiple VEGF-A dependent anticoagulant factor, protein S, inhibits - The vitamin K

  2012cites this paper
• Co-localization of prothrombin fragment F1+2 and VEGF-R2-bound VEGF in human colon cancer.

  2011cites this paper
• Thrombomodulin Is Silenced in Malignant Mesothelioma by a Poly(ADP-ribose) Polymerase-1-mediated Epigenetic Mechanism*

  2011cites this paper